Medpace Presentations & Investor Relations material

A therapeutically focused leader in research-based drug development, Medpace builds strong strategic partnerships with select Sponsors to advance the most efficient and cost-effective path to drug approval. As a full service, global Clinical Research Organization (CRO), Medpace sees itself as a steward of your drug, leveraging its extensive medical and regulatory expertise to deliver additional input, strategy, and efficiencies to each and every phase of the clinical trial. From custom solutions addressing the needs of small and midsize biotechnology companies to full-service offerings for global pharmaceutical companies, Medpace has the breadth, depth, and flexibility to deliver a superior result, specific to your needs, on six continents.

medpace.com

Medpace presentations

Q3 2021 Financial Results image

Q3 2021 Financial Results

Medpace logo
Medpace
Medpace Q2 2022 Financial Results image

Medpace Q2 2022 Financial Results

Medpace logo
Medpace
Medpace Q4 2016 Financial Results image

Medpace Q4 2016 Financial Results

Medpace logo
Medpace
Q4 2021 Financial Results image

Q4 2021 Financial Results

Medpace logo
Medpace
Baird 2016 Global Healthcare Conference image

Baird 2016 Global Healthcare Conference

Medpace logo
Medpace